Previous close | 95.24 |
Open | 94.50 |
Bid | 94.54 x 30000 |
Ask | 95.08 x 30000 |
Day's range | 94.50 - 94.50 |
52-week range | 80.98 - 105.25 |
Volume | |
Avg. volume | 19 |
Market cap | 5.064B |
Beta (5Y monthly) | 0.15 |
PE ratio (TTM) | 32.93 |
EPS (TTM) | 2.87 |
Earnings date | N/A |
Forward dividend & yield | 1.15 (1.22%) |
Ex-dividend date | 20 May 2024 |
1y target est | N/A |
Q1 revenue plunged 20.6% year-on-year to 289.6 million euros ($318.79 million), leading to a 40.6% shrink in net profit, which came in at 41.7 million euros, the company said in a note. Revenue from COVID-related business unit dropped 78.5% in the first quarter, in line with an expected 75% decrease year-on year. DiaSorin confirmed its 2023 guidance for the full year, which sees total revenue down 14% on a yearly basis.